Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P MALEK

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Immunity|May 29, 2021
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumoniaStefanie Kreutmair, Susanne Unger, Nicolás Gonzalo Núñez, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2022
Preexisting comorbidities shape the immune response associated with severe COVID-19Stefanie Kreutmair, Manuel Kauffmann, Susanne Unger, et al.
Journal of Hepatology|March 9, 2016
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER studyMichael Bitzer, Marius Horger, Edoardo G Giannini, et al.
Cell Metabolism|May 8, 2024
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Cell Death & Disease|October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerAnna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.
Cancer Discovery|May 27, 2018
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.
Cancer Cell|February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityLukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Zeitschrift Fur Gastroenterologie|November 19, 2013
[Diagnosis of and therapy for hepatocellular carcinoma]T F Greten, N P Malek, S Schmidt, et al.
Nature|February 4, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillanceXin Li, Cynthia Lebeaupin, Aikaterini Kadianaki, et al.
Physical Review Letters|September 15, 2025
Measurement of WWZ and ZH Production Cross Sections at sqrt[s]=13 and 13.6 TeVA Hayrapetyan, V Makarenko, A Tumasyan, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Immunity|May 29, 2021
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumoniaStefanie Kreutmair, Susanne Unger, Nicolás Gonzalo Núñez, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2022
Preexisting comorbidities shape the immune response associated with severe COVID-19Stefanie Kreutmair, Manuel Kauffmann, Susanne Unger, et al.
Journal of Hepatology|March 9, 2016
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER studyMichael Bitzer, Marius Horger, Edoardo G Giannini, et al.
Cell Metabolism|May 8, 2024
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Cell Death & Disease|October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerAnna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.
Cancer Discovery|May 27, 2018
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.
Cancer Cell|February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityLukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Zeitschrift Fur Gastroenterologie|November 19, 2013
[Diagnosis of and therapy for hepatocellular carcinoma]T F Greten, N P Malek, S Schmidt, et al.
Nature|February 4, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillanceXin Li, Cynthia Lebeaupin, Aikaterini Kadianaki, et al.
Physical Review Letters|September 15, 2025
Measurement of WWZ and ZH Production Cross Sections at sqrt[s]=13 and 13.6 TeVA Hayrapetyan, V Makarenko, A Tumasyan, et al.
Pageof 19